SCHEMBL3974414

SCHEMBL3974414

N#Cc1c(O)ccc(C(=O)OC(=O)c2occc2-c2cccs2)c1C(=O)NN

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.35
POLB P06746 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 6/20 0.34
HPGD P15428 4/20 0.34
ADORA2A P29274 4/20 0.34
ADORA1 P30542 4/20 0.34
HSD17B10 Q99714 4/20 0.34
ADORA2B P29275 3/20 0.34
MAPT P10636 4/20 0.33
NPSR1 Q6W5P4 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ALDH1A1 P00352 7/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ALOX15 P16050 3/20 0.32
KEAP1 Q14145 1/20 0.32
USP2 O75604 1/20 0.32
HTT P42858 1/20 0.32
PIM1 P11309 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3976979 0.85 IKBKB (0.34) GAAALDH1A1KISS1R
SCHEMBL3974765 0.85 ALDH1A1 (0.36) GAAPOLBMEN1KMT2AKDM4E
SCHEMBL3978191 0.83 ALDH1A1 (0.35) GAAPOLBMEN1KMT2AKDM4E
SCHEMBL3985003 0.83 NPC1 (0.34) POLBKDM4EMAPTL3MBTL1ALDH1A1
SCHEMBL3977150 0.81 KISS1R (0.38) ADORA1KISS1R
SCHEMBL3977209 0.80 HSD17B10 (0.34) POLBMEN1KMT2AKDM4EHPGD
SCHEMBL3978276 0.80 GRM2 (0.34) GAAMEN1KMT2AKDM4EHPGD
SCHEMBL3985135 0.80 ALDH1A1 (0.32) MEN1KMT2AMAPTNPSR1ALDH1A1
SCHEMBL3976647 0.79 IDO1 (0.34) SMN1; SMN2KISS1R
SCHEMBL3975349 0.79 MCL1 (0.40) GAAKDM4EMAPTALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 GAA 1023/4885POLB 4676/4885MEN1 1481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.